Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin
NCT00401661
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
110
Enrollment
INDUSTRY
Sponsor class
Conditions
Prostatic Hyperplasia
Interventions
DRUG:
Alfuzosin
Sponsor
Sanofi